• Product NameBCL9 Antibody
• Host SpeciesRabbit
• ClonalityPolyclonal
• PurificationAntigen affinity purification
• ApplicationsIHC
• Species ReactivityHu
• SpecificityThe antibody detects endogenous levels of total BCL9 protein.
• Immunogen Typepeptide
• Immunogen DescriptionSynthetic protein corresponding to residues near the C terminal of human BCL9
• Target NameBCL9
• Alternative Names    LGS
• Accession No. Swiss-Prot:O00512
  NCBI Gene ID:607
  NCBI Protein:BC116451
• UniprotO00512
• Gene ID607;
• Concentration 0.5mg/ml
• Formulation Rabbit IgG in pH7.4 PBS, 0.05% NaN3, 40% Glycerol.
• Storage Store at -20˚C

• 
  Immunohistochemistry: 1: 25-100

BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies.

• The image on the left is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using 46342(BCL9 Antibody) at dilution 1/30, on the right is treated with fusion protein. (Original magnification: x200)
• The image on the left is immunohistochemistry of paraffin-embedded Human cervical cancer tissue using 46342(BCL9 Antibody) at dilution 1/30, on the right is treated with fusion protein. (Original magnification: x200)

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting